Trump Wanted FDA To Fast-Track Blood Plasma Therapy. What Is It?
The president criticized the FDA this week for not giving emergency use approval to an experimental treatment for COVID-19. Scientists argue that the therapy still lacks sufficient evidence.
President Trump suggested in recent comments that there is a treatment for COVID-19 that members of his own administration are slow-walking to thwart his reelection bid.
The treatment is something called convalescent plasma. Since April, the Food and Drug Administration has to broaden the use of convalescent plasma and test its safety and effectiveness.
